CIK: 0001595851 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Feb 18, 2021
Total Value: $449M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| QQQ | INVESCO QQQ TR | 100,000 | $31.37M | 7.0% | $313.74 | — | — | Put | 46090E103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,350,000 | $30.02M | 6.7% | $22.24 * | $18.21 | +13.9% | COM | 87164F105 |
| — | TRILLIUM THERAPEUTICS INC | 1,950,000 | $28.68M | 6.4% | $14.71 | $7.71 | — | COM NEW | 89620X506 |
| RCKT | ROCKET PHARMACEUTICALS INC | 500,000 | $27.42M | 6.1% | $54.84 * | $19.92 | +83.0% | COM | 77313F106 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 500,000 | $23.2M | 5.2% | $46.40 * | $24.73 | +60.5% | COM | 462260100 |
| APLS | APELLIS PHARMACEUTICALS INC | 325,000 | $18.59M | 4.1% | $57.20 * | $42.30 | 0.0% | COM | 03753U106 |
| — | CONSTELLATION PHARMCETICLS I | 625,000 | $18M | 4.0% | $28.80 | $42.72 | — | COM | 210373106 |
| ASND | ASCENDIS PHARMA A/S | 105,000 | $17.51M | 3.9% | $166.78 | $130.34 | — | SPONSORED ADR | 04351P101 |
| ARVN | ARVINAS INC | 205,000 | $17.41M | 3.9% | $84.93 * | $28.07 | +22.8% | COM | 04335A105 |
| — | MERSANA THERAPEUTICS INC | 600,000 | $15.97M | 3.6% | $26.61 | $10.98 | — | COM | 59045L106 |
| FATE | FATE THERAPEUTICS INC | 165,000 | $15M | 3.3% | $90.93 * | $25.07 | +147.7% | COM | 31189P102 |
| IMVT | IMMUNOVANT INC | 300,000 | $13.86M | 3.1% | $46.19 | $11.17 | +314.0% | COM | 45258J102 |
| FOLD | AMICUS THERAPEUTICS INC | 600,000 | $13.85M | 3.1% | $23.09 * | $14.57 | +40.3% | COM | 03152W109 |
| TGTX | TG THERAPEUTICS INC | 250,000 | $13.01M | 2.9% | $52.02 * | $18.29 | +84.7% | COM | 88322Q108 |
| TVTX | TRAVERE THERAPEUTICS INC | 475,000 | $12.95M | 2.9% | $27.25 * | $23.35 | 0.0% | COM | 89422G107 |
| COGT | COGENT BIOSCIENCES INC | 1,100,000 | $12.35M | 2.8% | $11.23 * | $10.99 | 0.0% | COM | 19240Q201 |
| — | MIRATI THERAPEUTICS INC | 50,000 | $10.98M | 2.4% | $219.64 | $82.63 | — | Call | 60468T105 |
| — | MIRATI THERAPEUTICS INC | 50,000 | $10.98M | 2.4% | $219.64 | $82.63 | — | COM | 60468T105 |
| XENE | XENON PHARMACEUTICALS INC | 700,000 | $10.77M | 2.4% | $15.38 * | $12.88 | -9.2% | COM | 98420N105 |
| KURA | KURA ONCOLOGY INC | 325,000 | $10.62M | 2.4% | $32.66 * | $26.10 | +34.6% | COM | 50127T109 |
| — | IVERIC BIO INC | 1,375,000 | $9.501M | 2.1% | $6.91 | $7.44 | — | COM | 46583P102 |
| — | SURFACE ONCOLOGY INC | 1,000,000 | $9.24M | 2.1% | $9.24 | $6.66 | — | COM | 86877M209 |
| — | FIVE PRIME THERAPEUTICS INC | 500,000 | $8.505M | 1.9% | $17.01 | $17.01 | — | COM | 33830X104 |
| SRPT | SAREPTA THERAPEUTICS INC | 40,000 | $6.82M | 1.5% | $170.50 * | $151.97 | -2.5% | COM | 803607100 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 900,000 | $6.705M | 1.5% | $7.45 * | $4.33 | +18.9% | COM | 09058V103 |
| MLTX | HELIX ACQUISITION CORP | 500,000 | $5.685M | 1.3% | $11.37 | $11.37 | — | COM CL A | G4444C102 |
| — | VERONA PHARMA PLC | 810,000 | $5.67M | 1.3% | $7.00 | $6.24 | — | SPONSORED ADS | 925050106 |
| — | VISTAGEN THERAPEUTICS INC | 2,440,000 | $4.734M | 1.1% | $1.94 | $1.94 | — | COM NEW | 92840H202 |
| ALDX | ALDEYRA THERAPEUTICS INC | 650,000 | $4.459M | 1.0% | $6.86 * | $4.21 | +66.6% | COM | 01438T106 |
| ACRS | ACLARIS THERAPEUTICS INC | 650,000 | $4.206M | 0.9% | $6.47 * | $4.22 | 0.0% | COM | 00461U105 |
| IMUX | IMMUNIC INC | 265,000 | $4.052M | 0.9% | $15.29 * | $16.38 | +9.6% | COM | 4525EP101 |
| KALV | KALVISTA PHARMACEUTICALS INC | 200,000 | $3.798M | 0.8% | $18.99 * | $15.74 | +9.0% | COM | 483497103 |
| MRNA | MODERNA INC | 35,000 | $3.656M | 0.8% | $104.46 * | $54.76 | +84.7% | Put | 60770K107 |
| — | CURIS INC | 425,000 | $3.481M | 0.8% | $8.19 | $8.19 | — | COM NEW | 231269200 |
| — | SIERRA ONCOLOGY INC | 200,000 | $3.206M | 0.7% | $16.03 | $16.03 | — | COM NEW | 82640U404 |
| — | CTI BIOPHARMA CORP | 750,000 | $2.415M | 0.5% | $3.22 | $3.22 | — | COM | 12648L601 |
| — | MILLENDO THERAPEUTICS INC | 925,000 | $1.98M | 0.4% | $2.14 | $1.63 | — | COM | 60040X103 |
| — | AMARIN CORP PLC | 400,000 | $1.956M | 0.4% | $4.89 | $4.72 | — | SPONS ADR NEW | 023111206 |
| — | APTEVO THERAPEUTICS INC | 50,000 | $1.833M | 0.4% | $36.66 | $36.66 | — | COM NEW | 03835L207 |
| WVE | WAVE LIFE SCIENCES LTD | 200,000 | $1.574M | 0.4% | $7.87 * | $9.41 | -10.8% | SHS | Y95308105 |
| — | OTONOMY INC | 200,000 | $1.294M | 0.3% | $6.47 | $6.47 | — | COM | 68906L105 |
| — | SATSUMA PHARMACEUTICALS INC | 200,000 | $922K | 0.2% | $4.61 | $26.31 | — | COM | 80405P107 |
| BIIB | BIOGEN INC | 2,200 | $539K | 0.1% | $245.00 * | $278.91 | -7.1% | COM | 09062X103 |